Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
#f |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
11/21/24 16:24 | 11/19/24 | BNTC | Health | Drug | Pharmaceutical Preparations | Suvretta Capital Management, LLC | NY | DT | 1 | P.m | 417 | 10.05 | 0 | 41 | 5 | 950 | I | |||||||||||||||
8/14/23 17:13 | 8/11/23 | BNTC | Health | Drug | Pharmaceutical Preparations | Boston Megan | CA | DO | Exec Dir | 1 | P.d | 0 | 0.00 | 0 | 26 | 999% | 26 | D | ||||||||||||||
8/14/23 17:10 | 8/11/23 | BNTC | Health | Drug | Pharmaceutical Preparations | Buchi J Kevin | CA | D | 1 | P.d | 0 | 0.00 | 0 | 52 | 999% | 52 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |